Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00563160
Verified July 2010 by Hospital Authority, Hong Kong. Recruitment status was: Recruiting
To study the activity of chemotherapy with Gemzar-carboplatin in the preoperative setting for operable stages of non-small-cell lung cancer and to identify novel molecular markers correlated with chemosensitivity and prognosis
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:
Histologically or cytologically proven, newly diagnosed primary bronchogenic non-small cell lung cancer
Measurable or evaluable tumour on chest X-ray or CT scan.
No multiple ipsilateral or contralateral parenchymal tumours
Stage I(exceptT1N0),II,IIIa disease as shown by PET-CT